7-[(2S,5S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-4-methoxy-9-(2-morpholin-4-ylacetyl)-8,10-dihydro-7H-tetracene-5,12-dione
-
![7-[(2S,5S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-4-methoxy-9-(2-morpholin-4-ylacetyl)-8,10-dihydro-7H-tetracene-5,12-dione structure](https://file.echemi.com/fileManage/upload/canonicalSmiles/20220812/923ae6c1b06a4291a637e6044d5e58b1.png "7-[(2S,5S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-4-methoxy-9-(2-morpholin-4-ylacetyl)-8,10-dihydro-7H-tetracene-5,12-dione")
7-[(2S,5S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-4-methoxy-9-(2-morpholin-4-ylacetyl)-8,10-dihydro-7H-tetracene-5,12-dione
structure -
-
CAS No:
76549-16-1
-
Formula:
C31H36N2O11
-
Chemical Name:
7-[(2S,5S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-4-methoxy-9-(2-morpholin-4-ylacetyl)-8,10-dihydro-7H-tetracene-5,12-dione
-
Synonyms:
76549-16-1;14-Morpholinodaunorubicin;DTXSID90997894;BRN 1203937;3,5,12-Trihydroxy-10-methoxy-3-[(morpholin-4-yl)acetyl]-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxyhexopyranoside;5,12-Naphthacenedione, 7,8,9,10-tetrahydro-10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-1-methoxy-8-(4-morpholinylacetyl)-6,8,11-trihydroxy-, (8S-cis)-
-
CAS No:
7-[(2S,5S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-4-methoxy-9-(2-morpholin-4-ylacetyl)-8,10-dihydro-7H-tetracene-5,12-dione Basic Attributes
612.6 g/mol
612.23190997 g/mol
Computed Properties
Molecular Weight:612.6
XLogP3:1.1
Hydrogen Bond Donor Count:5
Hydrogen Bond Acceptor Count:13
Rotatable Bond Count:6
Exact Mass:612.23190997
Monoisotopic Mass:612.23190997
Topological Polar Surface Area:198
Heavy Atom Count:44
Complexity:1100
Defined Atom Stereocenter Count:2
Undefined Atom Stereocenter Count:4
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes
Request for Quotation